|
Version 4.0.200811 |
|
This is the complete description of the cell line that you requested.
By selecting a generic term (e.g. SPECIES) you will go to the corresponding list of controlled terms, while by selecting a specific term you will go to the list of corresponding cell line names.
SPECIES: human, Japanese
TISSUE/ORGAN: peripheral blood
TUMOR: leukemia, acute myeloid
DSMZ catalog code: ACC 220
Morphology: round cells growing singly or in small clumps in suspension
Description: human acute myeloid leukemia established from the peripheral blood of a 7-year-old Japanese man with acute myeloid leukemia (AML FAB M2) (in 2nd relapse after bone marrow transplantation) in 1989; cells carry the t(8;21) ETO-AML1 fusion gene confirmed as human with IEF of AST, PEP B
Viruses: ELISA: reverse transcriptase positive; PCR: EBV-, HBV-, HCV-, HHV-8-, HIV-, HTLV-I/II-
Depositor: Dr. N. Kamada, Hiroshima University, Hiroshima, Japan
General Restrictions
Available in the following LABORATORY:
-
German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig)
90% RPMI 1640 + 10% FBS split saturated culture about 1:2 to 1:3 every 3 days; optimal density at about 0.5 x 106 cells/ml; viability may drop below 50% within the first 24 hours after thawing; we recommend to start culture with a cell concentration of >1 x 106 cells/ml and to cultivate initially in 24-well plates in the presence of 20% FBS; a significant amount of cell debris is always visible in the background which might be due to granula or other intracellular material at 37C with 5% CO2 saturation density at about 1.0 x 106 cells/ml;
doubling time of ca. 48-72 hours;
frozen with 70% medium, 20% FBS, 10% DMSO at about 4-5 x 106 cells/ampoule;
negative in DAPI, microbiological culture, RNA hybridization, PCR assays;
Validated by: cytogenetics 1 (human hypodiploid karyotype; 45<2n>X,-Y, -9, -13, -16, +3mar, t(8;21)(q22;q22), der(9)t(9;?)(p22;?), der(15)t(?9;15)((?q11;?p11); carries both partners of 8;21 translocation associated with AML (mainly FAB M2)) * DNA fingerprinting (unique, heterozygous profile with pYNH24 probe) * immunological analysis (CD3- CD4+ CD13+ CD14- CD15+ CD19- CD33+ CD34+ CD38+ HLA-DR+ CD68- CD71+) * isoenzymes (confirmed as human with IEF of AST, PEP B) * reverse transcriptase (reverse transcriptase positive; negative for HTLV-I/II, HIV-1)
Bibliographic references:
- Blood 1991;77:2031-2036 - PMID: 2018839
For information, get in touch with:
Istituto Nazionale per la Ricerca sul Cancro,
c/o Centro Biotecnologie Avanzate, Torre B - Piano 2
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Tel: +39-0105737-289, Fax: +39-0105737-293
Email: assunta.manniello@istge.it